Elekta Unity News Today

Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $6.52 and last traded at $6.71, with a volume of 14485 shares trading hands. The stock had previously closed at $6.62. Elekta AB (publ) Price Performance The firm […]

Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) and Fortrea (NASDAQ:FTRE – Get Free Report) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk. Profitability This table compares Elekta AB (publ) […]

BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) and Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability. Earnings and Valuation This table compares […]

Shares of Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) have been given an average rating of “Hold” by the six brokerages that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating and three have assigned a buy rating to the company. Separately, Barclays initiated coverage […]

Mary Bird Perkins Cancer Center is launching a $10 million adaptive radiation therapy program that uses a technology designed in Sweden to enhance the precision of radiation doses, the organization

Shares of Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) have earned an average rating of “Reduce” from the seven analysts that are presently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a sell rating and three have assigned a buy rating to the company. Separately, Barclays started coverage on […]

Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) has earned a consensus recommendation of “Reduce” from the seven analysts that are covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a sell recommendation and three have issued a buy recommendation on the company. EKTAY has been the subject of a […]

How Elekta is working to produce radiotherapy products that maximize positive impact The radiation therapy industry is focusing intently on how to reduce the environmental...

Aclarion (NASDAQ:ACON – Get Free Report) and Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership. Analyst Recommendations This is a summary of current […]

Objective. This study aimed to investigate the dosimetric impact of using population-based relative electron density (RED) overrides in lieu of simulation computerized tomography (CT) in a magnetic resonance linear accelerator (MRL) workflow for male pelvis patients. Additionally, the feasibility of using prostate specific membrane antigen positron emission tomography/CT (PSMA-PET/CT) scans to assess patients' eligibility for this proposed workflow was examined.Approach. In this study, 74 m...